28.4 C
Vientiane
Monday, August 18, 2025
spot_img
Home Blog Page 176

Makera Launches Cyclone Dust Collector: The Must-Buy Solution for Cleaner Desktop Fabrication

MIDDLETOWN, Del., July 28, 2025 /PRNewswire/ — Makera, the pioneer of intelligent desktop CNC (Computer Numerical Control) solutions, is expanding its ecosystem with the launch of a new product: the Makera Cyclone Dust Collector. But unlike their previous launches, including the Carvera and Carvera Air, this one is not a new milling machine, instead an accessory which advances usability for all desktop subtractive manufacturing processes.


Makera Cyclone Dust Collector

The Makera Cyclone Dust Collector is far more than a traditional shop vacuum. This new dust collector optimizes the user experience by offering a truly integrated desktop manufacturing system through its design features and performance. And what’s even more exciting is that the presale launch will kick off during Makera’s next Livestream on July 28th at 7 PM EDT via YouTube, Instagram, and Facebook.

High Performance Meets Seamless Integration

Makera’s Cyclone Dust Collector is a plug and play system for any desktop CNC, not just the Carvera and Carvera Air. It delivers unmatched performance with 12 kPa suction, 900 L/min airflow, and a triple-layer filtration system that captures 99.99% particles. Despite its powerful performance, which is truly unique for a vacuum of this size, the Makera Cyclone Dust Collector is also quiet, never exceeding 70 db, which allows it to offer minimal noise and maintenance. A 6-liter dustbin offers capacity for extended continuous machining sessions without interruption.

It’s clever too. The Cyclone Dust Collector has auto start / stop sensor functions which can be triggered by Makera’s CNCs, a key feature intended to offer a seemless way to integrate the collector into the desktop manufacturing workflow. And like Makera’s CNC milling machines, the Cyclone Dust Collector is designed to work with a wide range of materials including wood, fibers, metals, even filtering light laser engraving operations too.

“At Makera, we believe the user experience is just as important as machine performance. The Makera Cyclone Dust Collector is our response to a challenge every desktop manufacturer faces: keeping workspaces clean, quiet, and hassle-free.” said Josh Zhang, CEO of Makera, “By integrating smart features and plug-and-play design, we’re not just adding a vacuum to the desktop manufacturing infrastructure. We’re removing friction from the entire workflow.”

From Desktop CNC Maker to Desktop Manufacturing Ecosystem Builder

The launch of the Cyclone Dust Collector also marks a strategic shift for the company. Since the launch of their first CNC, the Carvera in late-2021, Makera has worked to not only change the way we think about desktop production technology, but now also work to build the infrastructure layer for compact, clean, and intelligent manufacturing spaces & ecosystems. This has been a project in the works following the launch of their second machine, the Carvera Air in early 2024, through the launch of Makera CAM – an intuitive approach to preparing designs for manufacturing later that same year. Now, the Makera Cyclone Dust Collector is another step towards the company’s mission.

The Cyclone Dust Collector will be available for pre-order starting on July 28th during Makera’s Livestream launch event at 7 PM EDT. Preorders can be placed directly on Makera’s website at www.makera.com, or www.global.makera.com for customers outside of North America. The retail price of the Cyclone Dust Collector is $599 USD, and a $110 coupon can be secured for the first 500 customers for just $10 during the pre-sale from July 28th.

About Makera, Inc:

Makera, Inc. is a pioneer in the field of desktop CNC milling technology, dedicated to empowering makers with safe, smart, and versatile manufacturing solutions. By continuously innovating and reducing barriers to creative production, Makera fuels a global community of makers, transforming ideas into reality.

The company’s desktop CNC machines represent years of focused engineering development. Among its cutting-edge products are the Carvera and Carvera Air, two desktop CNC machines designed for precision, reliability, and ease of use. These machines are perfect for a wide range of applications, from prototyping to small-scale production, and manufacturing for scientific research, enabling makers to bring their visions to life with professional-grade results.

 

XellSmart Completed World’s First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury

SUZHOU, China, July 28, 2025 /PRNewswire/ — XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its “world’s first” China NMPA & US FDA-approved registrational clinical trial. This Phase I China registrational clinical trial for XS228 Cell Injection – the world’s first “off-the-shelf”, allogeneic, iPSC-derived, spinal neural progenitor cell therapy targeting major neurological disorders, specifically spinal cord injury (SCI) – has commenced. The clinical trial initiation meeting was held at The Third Affiliated Hospital of Sun Yat-sen University (SYSU-3) in Guangzhou. Following this, the world’s first patient dosing with the therapy was successfully administered.

Following the world’s first transplantation of clinical-grade, iPSC-derived neural progenitor cells in the registrational clinical trial, the initial subject exhibited no surgical or perioperative complications or other adverse safety events. All monitored parameters remained within normal ranges. The subject successfully completed the observation period uneventfully and has now entered the formal follow-up period.

XellSmart has achieved a significant milestone in global central nervous system (CNS) injury repair — having completed the world’s first patient dosing in its China registrational clinical trial. This landmark event serves as a benchmark for evaluating the safety of transplanted, iPSC-derived, spinal-cord neural progenitor cells and analyzing their potential therapeutic effects on patients with spinal cord injury (SCI).

XellSmart is a leading biotechnology company dedicated to developing innovative iPSC-derived cell therapies. To date, the company has secured seven Investigational New Drug (IND) approvals from both China’s National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA) for registrational clinical trials. All approved programs focus on clinical-grade, off-the-shelf, allogeneic, iPSC-derived cell therapies targeting central nervous system (CNS) diseases with significant unmet medical needs, including:

  • Parkinson’s Disease (PD): The world’s second most common neurodegenerative disorder, affecting over 10 million patients globally (Phase I clinical trials ongoing in China and approved in the US);
  • Spinal Cord Injury (SCI): A major CNS disorder impacting more than 10 million patients worldwide with no effective treatment (a first-in-class therapy; a Phase I clinical trial ongoing in China and approved in the US);
  • Amyotrophic Lateral Sclerosis (ALS): A devastating rare neurodegenerative disease (a first-in-class therapy; a Phase I/II clinical trial ongoing in China and approved in the US; granted Orphan Drug Designation by the US FDA).

For funding and BD cooperation, please contact: BD@xellsmart.com

XellSmart, standing at the forefront of advancing innovative iPSC-based therapies, is committed to developing clinical-grade, off-the-shelf, allogeneic, iPSC-derived cell therapies targeting major and intractable central nervous system (CNS) diseases with no effective treatment options. The following is an overview of its clinical milestones:

In 2023, China’s first iPSC-derived cell therapy (XS228 injection), developed by XellSmart, received Orphan Drug Designation (ODD) from the US FDA for the treatment of ALS.

In 2024China’s first national-level registered clinical study of an iPSC-derived cell therapy for Parkinson’s disease—also developed by XellSmart—was approved and initiated, including the first case treated in China.

In 2024, the world’s first national-level registered clinical study of a subtype-specific, iPSC-derived, neural progenitor cell therapy (XS228 injection) for ALS was approved. Multiple patients, including the world’s first ALS case treated with this approach, received the therapy with preliminary data showing good safety profiles and slowed disease progression.

In 2025, China’s first registrational Phase I clinical trial of an off-the-shelf, allogeneic, iPSC-derived, dopaminergic neural progenitor cell therapy (XS411 injection) for Parkinson’s disease was launched, led by the National Neurological Disease Medical Center at Beijing Tiantan Hospital.

In 2025, China’s first randomized, double-blind, controlled Phase I/II clinical trial of XS411 injection was initiated to treat early-onset Parkinson’s disease (EOPD), led by Huashan Hospital of Fudan University, a National Neurological Disease Medical Center.

In 2025, the world’s first registrational Phase I clinical trial of an off-the-shelf, allogeneic, iPSC-derived, subtype-specific, neural progenitor cell therapy was launched by The Third Affiliated Hospital of Sun Yat-sen University, targeting SCI.

In 2025, the world’s first Phase I/II registrational clinical trial of XS228 injection — an off-the-shelf, allogeneic, iPSC-derived, subtype-specific, neural progenitor cell therapy — was initiated by Peking University Third Hospital, targeting ALS.

XellSmart has established a fully dedicated and internationally competitive team focusing on development of clinical-grade, allogeneic, off-the-shelf, iPSC-derived cell therapies for central nervous system (CNS) diseases that currently lack effective treatment options. XellSmart has built a portfolio of proprietary, globally leading industrial technologies and platforms, fueling sustained in-house innovation centered on its core business. To develop iPSC-derived cell therapy candidates, XellSmart has established and operates an R&D center, a B+ and A-grade GMP manufacturing facility, and a quality control center spanning over 5,000 square meters.

With completed core CMC development, fully integrated clinical-grade manufacturing processes and quality control systems in place, XellSmart has successfully produced clinical batches of multiple GMP-grade, iPSC-derived, subtype-specific, neural progenitor cell therapies, currently deployed in multiple clinical trials.

XellSmart has secured multiple rounds of financing, collectively led by renowned market-driven venture capital firms including Qiming Venture Partners, Eli Lilly Asia Ventures, Sequoia Capital China (Hongshan), and others.

For funding and BD cooperation, please contact: BD@xellsmart.com 

Introducing Antigravity: The Future of Aerial Exploration and Storytelling

LOS ANGELES, July 28, 2025 /PRNewswire/ — Today marks the official launch of Antigravity, a new drone brand with a bold mission: to redefine aerial exploration and storytelling.

Insta360 × Antigravity: The Future is Up
Insta360 × Antigravity: The Future is Up

Incubated by Insta360 in collaboration with third parties, Antigravity isn’t content with simply releasing another drone into an already crowded sky. Instead, it’s creating an entirely new category — combining the world’s first 360 drone with true immersive capture. All packed into a sub-249g form factor, with 8K resolution to match.

Today, most drones are tools. With Antigravity, we’re aiming higher,” says BC Nie, Head of Marketing at Antigravity. “While others compete on specs, we’ve flipped the script, reimagining what a drone should be able to do. The result is something that empowers real emotion and enables experiences like freedom, creativity, and discovery for everyone.

The Idea: 360 Immersive Flight

At the heart of Antigravity’s design philosophy is the concept of 360 immersive flight. The brand aims to own this space completely, and replace the technical complexity inherent in both drone flying and 360-degree videography with expressive, story-first experiences that are easy to master yet exceptionally powerful.

Inspired by You. Made for Everyone.

Ease of use is the starting point for all Antigravity products. Users don’t need experience. They don’t need a checklist — the drones are operated intuitively. While the rest of the industry is designing products for experts, Antigravity is building drones for everyone; beginners, experts, and everyone in between.

A Collaborative Approach to Product Design

Antigravity is also redefining how products are designed by making community and collaboration a core part of its ethos. Through the Antigravity Hub, the company’s co-creation program, enthusiasts and community members are invited to help shape the future of Antigravity’s products. Ideas that inspire future products or features will be rewarded.

Technology Has Caught Up

Antigravity — and its upcoming first product — launches when hardware, software, and user expectations have finally aligned. This drone is set to revolutionize the industry, introducing several world-firsts in drone design. To ensure that Antigravity products are used solely for exploration and storytelling, all drones will include safety features such as payload detection to prevent misuse or unauthorized modifications.

Antigravity’s first drone will be unveiled in August 2025. More information is available at www.antigravity.tech.

About Antigravity

Antigravity is a consumer drone company reimagining how people experience flight. Incubated by Insta360 in collaboration with third parties, Antigravity develops powerful 360 drones that are immersive, creator-ready, and easy for anyone to fly — whether capturing family moments, weekend adventures, or creative projects. Its mission is to make drone flight more inclusive, expressive, and fun. By combining 360 capture with intuitive control systems, Antigravity is pioneering a new category of aerial exploration and storytelling. Built by a global team of engineers, designers, and creators, the company will unveil its first drone in August 2025.

Follow Antigravity on Facebook: https://www.facebook.com/AntigravityGlobal/
Follow Antigravity on X: https://x.com/Antigravity_HQ
Follow Antigravity on Instagram: https://www.instagram.com/antigravity_global/
Follow Antigravity on TikTok: https://www.tiktok.com/@antigravity_global
Follow Antigravity on LinkedIn: https://www.linkedin.com/company/antigravitytech/
Subscribe to Antigravity’s YouTube Channel: https://www.youtube.com/@Antigravity_Global

SHEIN X TEAMS UP WITH HOUSE OF ONE FOR A CHIC, ACCESSIBLE CAPSULE COLLECTION

The Collection Features Polished Staples, Soft Tailoring, and Affordable Indulgence for Every Moment on Your Calendar

LOS ANGELES, July 28, 2025 /PRNewswire/ — SHEIN X, the collaboration platform under global fashion and lifestyle online retailer SHEIN, introduces its latest designer drop: a limited-edition capsule with modern womenswear label House of One. Designed for women who dress with intention, the SHEIN X HOUSE OF ONE collection delivers timeless pieces that balance sophistication, comfort, and quiet confidence – all at accessible price points.

SHEIN X introduces its latest designer drop: a limited-edition capsule with modern womenswear label House of One.
SHEIN X introduces its latest designer drop: a limited-edition capsule with modern womenswear label House of One.

Featuring clean lines, soft tailoring, and thoughtful details like pleats, piped edges, and cinched waists, the 50-piece collection offers refined wardrobe staples made to meet the moment – whether it’s a Monday meeting, an after-hours event, or a well-earned day of rest. House of One’s signature aesthetic – feminine, flattering, and quietly confident – is reimagined through SHEIN’s lens of global accessibility and innovation.

“This collection embodies our belief that clothing should feel like a reward – elevated but never fussy,” said Ronaldo Engelbrecht, Lead Designer House of One. “Our goal was to create pieces that bring ease and elegance to everyday life, helping women feel composed, confident, and fully themselves. Collaborating with SHEIN X gave us the platform to share that message on a global scale, combining thoughtful design with incredible reach.”

Rooted in a palette of warm creams, charcoals, camel, and soft blue, the collection draws inspiration from heritage minimalism and everyday grace. Structured silhouettes are softened by draped fabrics and breathable knits, while linen blends offer tactile richness that wears beautifully over time. From wide-leg trousers and tailored sets to softly pleated skirts and refined day-to-night dresses, each piece is designed to move with real life – and feel like a moment of indulgence in the middle of it.

Made for the woman who dresses with purpose and shops with care, SHEIN X HOUSE OF ONE invites customers to experience what House of One calls affordable indulgence: timeless design that feels expensive – without the price tag.

Prices range from $9.29 to $48.39. The collection is available now, exclusively on SHEIN. Share your favorite looks using #SHEINXHouseofOne, and keep an eye out for future collaborations between SHEIN X and House of One.

 About SHEIN X: 

SHEIN X is a program under SHEIN – the global fashion and lifestyle online retailer – that collaborates with designers and creators to launch exclusive collections. Each release showcases the originality of talented creators worldwide and marries the essence of upscale fashion with affordability, giving a designer touch to all styles. To learn about SHEIN X, visit https://us.shein.com/campaigns/sheinxcollabs

About SHEIN: 

SHEIN is a global fashion and lifestyle online retailer, offering SHEIN branded apparel and products from a global network of vendors, all at affordable prices. Headquartered in Singapore, SHEIN remains committed to making the beauty of fashion accessible to all, promoting its industry-leading, on-demand production methodology for a smarter, future-ready industry. To learn more about SHEIN, visit www.sheingroup.com

 About House of One:

House of One is a modern womenswear label born from quiet strength and everyday grace—where refined tailoring meets feminine ease. Designed for the woman who leads with purpose and dresses with intention, our pieces reflect the rhythm of real life: full days, layered roles, and moments of pause in between. We believe clothing should offer more than function—it should offer a feeling. A sense of calm, capability, and quiet confidence. Each piece is crafted to flatter without effort, combining structured silhouettes with soft draping, subtle detail, and a touch of indulgence. For more information, visit https://houseofoneofficial.com/.

Press Contacts:

Kate Fosha George
kate.fosha@sheingroup.com 

Alyssa McDonald
amcdonald@sheingroup.com

Yanfeng Unveils 2024 ESG Report: Driving Sustainability Forward

SHANGHAI, July 28, 2025 /PRNewswire/ — Yanfeng, a leading global automotive supplier, officially released its 2024 Environmental, Social, and Governance (ESG) Report, showcasing significant progress across its sustainability initiatives. The report highlights the company’s unwavering commitment to responsible operations through measurable achievements in renewable energy adoption, circular economy practices, and social responsibility programs. 

Key achievements in 2024 include:

  • Renewable Energy: 42% of global energy was sourced from renewables, with solar contributing 4.2%.
  • Circular Economy: A 31% increase in recycled plastic resin purchases.
  • Industry Recognition: Maintained an A- CDP rating for climate disclosure and earned an EcoVadis Silver Medal.

“Our 2024 ESG accomplishments reflect our team’s dedication to integrating responsible practices throughout our operations,” said Zang Chungao, CEO, Yanfeng. “From renewable energy to sustainable materials, we’re creating long-term value for all stakeholders.”

Yanfeng is on track for its net-zero emissions target (Scope 1 & 2) by 2030, embedding sustainability into product development with recyclable materials and modular designs.

The company also strengthened its commitment to the UN Global Compact and Sustainable Development Goals through ethical operations and record employee volunteer hours.

The full 2024 ESG Report is available [here]. Yanfeng continues to innovate and collaborate, advancing sustainable mobility solutions worldwide.

About Yanfeng

Yanfeng is a leading global automotive supplier, focusing on interior, exterior, seating, cockpit electronics, and passive safety, and is exploring new business actively. Yanfeng has more than 240 locations and approximately 57,000 employees worldwide. The technical team of 4,100 experts is in 14 R&D centers and other regional offices, with complete capabilities including engineering and software development, styling, and test validation. Focusing on Smart Cabin and lightweight technology, Yanfeng supports automakers to explore future mobility and provide leading cabin solutions. For more information, please visit www.yanfeng.com.

DP WORLD SMART LOGISTICS NETWORK DELIVERS McLAREN RACING CAR TO FANS IN TRAFALGAR SQUARE

From Pit Lane to Piccadilly: World Endurance Championship (WEC) 2027 show car delivered from the circuit des 24 Heures du Mans to the F1 team’s McLaren Technology Centre for fan festival. Two destinations, 633 kilometres, one channel crossing – all in four days through the power of smart logistics

LONDON, July 28, 2025 /PRNewswire/ — Global logistics leader DP World and the McLaren F1 Team joined forces to deliver a feat of logistics and an unforgettable fan experience in London during the British Grand Prix week.

WEC show car on display at Trafalgar Square.
WEC show car on display at Trafalgar Square.

In a bold demonstration of the power of smart logistics, DP World orchestrated the time-critical delivery of McLaren Racing’s newly unveiled WEC 2027 show car from the Circuit de 24 Heures du Mans in France, to the McLaren Technology Centre in Woking, before the car made its way to the first ever Racing Live: London event in Trafalgar Square.

Stephen Whittingham, Executive Vice President, North Europe, at DP World, said: “The logistics operation was a test of precision and timing, which saw DP World deploy a bespoke, temperature-controlled glass container to ensure the safe and secure transit of McLaren Racing’s WEC show car under tight deadlines.”

“Leveraging our expansive European network, the move was executed seamlessly by our expert logistics teams, underscoring the company’s capabilities in supporting high-value, sensitive cargo for the automotive and motorsports industries.”

The WEC 2027 show car’s final destination, McLaren Racing Live: London, was set against the iconic backdrop of Trafalgar Square and brought the energy of Formula 1 to the Capital’s centre. As part of the fan experience, DP World partnered with the McLaren F1 Team to create the ‘Pit Stop Challenge’ using one of the McLaren Formula 1 Team show cars.

The challenge saw more than a thousand racing fans take up the chance to step into the shoes of a McLaren pit crew member and attempt a tyre change at the speed of a real F1 team. Queues stretched over an hour as fans eagerly awaited their chance to get hands-on with the dynamic show car of the current Constructors’ Championship leaders.

Follow DP World on:
X (Twitter): https://twitter.com/DP_World
LinkedIn: https://www.linkedin.com/company/dp-world

About DP World

DP World is reshaping the future of global trade to improve lives everywhere. Operating across six continents with a team of over 115,600 employees, we combine global infrastructure and local expertise to deliver seamless supply chain solutions. From Ports and Terminals to Marine Services, Logistics and Technology, we leverage innovation to create better ways to trade, minimizing disruptions from the factory floor to the customer’s door.

WE MAKE TRADE FLOW

Our partnerships

Our global sports partnerships in Golf, Cricket, Formula 1 and Sailing showcase our leadership in supply chain transformation. From delivering SailGP to supporting the ICC T20 Cricket World Cup and The Ryder Cup, DP World simplifies logistics, drives performance and changes what’s possible.

Our partnership with McLaren Racing
As the team’s Official Logistics Partner, our global reach and capabilities allow us to bridge the most complex supplier networks in Formula 1 and beyond. From next-generation blockchain technology to seamlessly connected multi-modal solutions, we consult with McLaren Racing to deliver efficiently and sustainably, so they’re always race-ready.

About McLaren Racing

McLaren Racing was founded by racing driver Bruce McLaren in 1963. The team entered its first Formula 1 race in 1966. McLaren has since won 21 Formula 1 world championships, 197 Formula 1 Grands Prix, the Indianapolis 500 three times, and the Le Mans 24 Hours at its first attempt.

McLaren Racing competes across five racing series. The team competes in the FIA Formula 1 World Championship with McLaren F1 drivers Lando Norris and Oscar Piastri, the NTT INDYCAR SERIES with Arrow McLaren drivers Pato O’Ward, Nolan Siegel and Christian Lundgaard, the ABB FIA Formula E World Championship as the NEOM McLaren Formula E Team with drivers Sam Bird and Taylor Barnard, and F1 Academy with Driver Development programme member Ella Lloyd. The team also competes in the F1 Sim Racing Championship as McLaren Shadow.

McLaren is a champion for sustainability in the sport and a signatory to the UN Sports for Climate Action Commitment. It is committed to achieving net zero by 2040 and fostering a diverse and inclusive culture in the motorsport industry. 

McLaren Racing – Official Website

For more insights into how DP World is reshaping global trade, visit our website: www.dpworld.com

 

NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal

NEW YORK, July 28, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal

Ashley Mastronardi delivers the pre-market update on July 28th

  • Stocks are up Monday morning as the U.S struck a trade deal with the EU ahead of President Trump’s August 1st deadline. This deal comes after the U.S reached agreements with Japan and Indonesia last week.
  • The Federal Reserve will hold its next two-day policy meeting on Tuesday and Wednesday. The Central Bank is expected to keep interest rates unchanged, but investors will listen closely to Chair Jerome Powell’s comments.
  • Wall Street will be paying attention to earnings this week as Microsoft, Meta, Amazon and Apple will all report.

Opening Bell
Southside Bancshares (NYSE: SBSI) celebrates the 65th anniversary of Southside Bank

Closing Bell
Seaport Entertainment (NYSE: SEG) celebrates the company’s one-year anniversary

Click here to download the NYSE TV App

Video – https://mma.prnasia.com/media2/2739198/NYSE_Market_Update_July_28.mp4 

 

Big Lake Capital, LLC, Led and Controlled by NMHI CEO, Converts $671,984 Note into Nature’s Miracle (“NMHI”) Common Stocks

ONTARIO, Calif., July 28, 2025 /PRNewswire/ — Nature’s Miracle Holding Inc. (NMHI) (“Nature’s Miracle” or the “Company”), a leader in vertical farming technology announce that Big Lake Capital, LLC (the “Investor”), an investment company led and controlled by CEO Tie “James” Li, converted $678,290 into 3,425,706 NMHI shares at a conversion price of $0.1980 pursuant to the Convertible Promissory Note signed on April 11, 2025, between the Company and Big Lake Capital.

Pursuant to the Convertible Promissory Note signed on April 11, 2025, the Investor is going to lend to the Company up to $2,000,000, with the initial tranche of $600,000 which was funded on April 11, 2025. Terms include an interest rate of 10% payable monthly and a term of one year. The Investor can choose to convert any amount funded plus accrued interest into shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) at a conversion price equal to $0.198 or 110% of the closing price of the Common Stock on April 11, 2025, the date of initial funding. 

Following the conversion, no amounts are outstanding under the note. The Company may borrow up to an additional amount of $1.342.428 under the note.

About Nature’s Miracle Holding Inc.

Nature’s Miracle (www.Nature-Miracle.com) is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture (“CEA”) industry in the U.S. The Company’s Common Stock trades on the OTCQB market (“OTCQB”) under the symbol “NMHI”.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature’s Miracle’s joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature’s Miracle’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature’s Miracle’s ability to develop and launch new products and services; Nature’s Miracle’s ability to successfully and efficiently integrate future expansion plans and opportunities; Nature’s Miracle’s ability to grow its business in a cost-effective manner; Nature’s Miracle’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature’s Miracle’s business model; developments and projections relating to Nature’s Miracle’s competitors and industry; and Nature’s Miracle’s approach and goals with respect to technology.

These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on the OTC; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature’s Miracle’s operates; the risk that Nature’s Miracle’s and its current and future collaborators are unable to successfully develop and commercialize Nature’s Miracle’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature’s Miracle’s is unable to secure or protect its intellectual property; the possibility that Nature’s Miracle’s may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature’s Miracle’s filings from time to time with the SEC.